Bill's excellent adventure

When a company goes from nowhere to a market value of $9.3 billion in just over a year, it’s not too surprising if the CEO ends up making headlines in everything from the Financial Times to Fortune. But it is surprising that the company was started by a Harvard professor who still says he sees himself as a medical scientist making drugs out of proteins. So does Bill Haseltine, founder of Human Genome Sciences, relish the lifestyle, the envy, the rivalries that the human genome has brought him? Is he really a genius and a visionary? And why does…